SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results triggered a sharp selloff as investors focused on softer Search and advertising performance, heavy AI infrastructure spending, and negative free cash flow despite strong Cloud growth. Traders are divided between concerns that AI is disrupting Search and spending may not pay off soon, and dip buyers who see Cloud growth and the broader business as reasons the reaction is overdone.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances announcement that it would present positive Phase 2 lifileucel results in previously treated metastatic lung cancer, alongside a precision-medicine update, drove attention as traders anticipated an expansion beyond melanoma. Many were enthusiastic about the potential, while others cautioned that detailed results and evidence of commercial execution still matter and that the move could meet sell-the-news pressure.

Alphabet Inc - Ordinary Shares - Class C

Alphabets quarterly earnings miss and heavy AI infrastructure spending, which pressured cash flow, triggered a sharp selloff and raised concerns about returns on investment and slowing search growth. Traders are divided between expecting further downside and viewing the drop as an overreaction, with bulls pointing to strong Google Cloud growth and buying the dip.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows quarterly earnings miss and softer outlook for contracted-revenue growth triggered a sharp selloff, despite revenue growth and a raised AI target. Traders debate whether the reaction reflects valuation and slowing growth or is an overreaction to an otherwise strong quarter, while some also worry AI could pressure software companies.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results beat expectations, led by accelerating Azure growth and strong AI-cloud demand, while capital spending came in below expectations. Traders largely welcomed the results and contrasted them with Alphabets weaker reaction, though some questioned the decline in free cash flow and whether the initial post-earnings rally would hold.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinets quarterly results triggered a sharp selloff despite beating estimates and raising its full-year outlook; traders focused on slowing product growth, softer service-revenue guidance, and margin compression after a steep run-up. The community is split between viewing the drop as an overreaction to a solid report and seeing it as a valuation reset justified by weaker growth mix.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

BlackRocks amended filing showing a larger 13.8% stake is being read by traders as a bullish signal, while discussion centers on the upcoming Q3 report and whether BRIUMVI sales growth and lower expenses will support results. Some expect a beat, but others are wary of a revenue miss or the stocks tendency to retreat after earnings.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Healths stronger-than-expected third-quarter results, raised outlook and share-repurchase authorization are driving attention and a sharp rally. Traders are reacting positively to the performance and debt-reduction progress, while some remain cautious about the companys substantial debt and whether the gains will hold.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Traders are focused on reported Upbit trading support changes for JASMY, with bearish posts treating them as a warning sign amid concerns about project transparency and progress. Others argue the impact is limited or overblown and are buying the dip, while the tokens broader decline adds to the debate.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Patent litigation over generic versions of Lupkynis is the main focus, with claim-construction deadlines extended and traders speculating that the delay could precede settlements; others are frustrated by the prolonged cases and limited company updates. Investors are also watching the upcoming Q3 report for evidence that Lupkynis sales growth is continuing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SPY Means for about 6 weeks the market was “stupid” for continuing to rise and then by Dec.24, it was “stupid” for continuing to fall 2/

Mouli

Joe Jackson

StockTwits for iOS

 Means for about 6 weeks the market was “stupid” for continuing to rise and then by Dec.24, it was “stupid” for continuing to fall 2/